AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $520.00
- 52-wk high
- $553.69
- High
- $533.78
- 52-wk low
- $374.17
- Low
- $517.34
- Prev close
- $515.55
Smart money
Earnings
Earnings came in 1.2% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.08B | $3.23B | $2.99B | $3.33B |
| Cost of what it sold | $414.8M | $466.0M | $392.8M | $489.2M |
| Gross profit | $2.66B | $2.76B | $2.59B | $2.84B |
| What it spent | ||||
| Research and development | $1.03B | $973.7M | $961.6M | $993.8M |
| Sales and admin | $445.1M | $487.0M | $493.7M | $582.2M |
| Other operating costs | — | — | — | $21.8M |
| Total operating expenses | $1.48B | $1.46B | $1.46B | $1.60B |
| What was left | ||||
| Operating profit | $1.19B | $1.30B | $1.14B | $1.25B |
| Interest on debt | $3.3M | $3.3M | — | — |
| Profit before tax | $1.30B | $1.33B | $1.25B | $1.39B |
| Tax | $215.9M | $139.9M | $221.5M | $292.0M |
| Net profit | $1.08B | $1.19B | $1.03B | $1.10B |
| EBITDA | $1.36B | $1.39B | $1.31B | $1.39B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
69balanced
20D volatility
31%annualized
52-week range
$374.17$553.69
20D support
News
What the news says
50 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
NeutralAug 17Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
BullishAug 17Satellos Bioscience Stock Drops 3.39% as Investors Weigh Duchenne Muscular Dystrophy Therapy, Clinical Development and Biotech Risk
Neutral
